'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

Tortured into confession : Two Palestinians recount hellish interrogation
23/05/2022
Long-lost recordings of Eichmann confessing to the Final Solution revealed
23/05/2022
Iran's Raisi vows 'blood revenge' over Revolutionary Guards member assassination
23/05/2022
Bennett loses second senior adviser in ten days
23/05/2022
A violent schism just exploded in Israel's most powerful Hasidic sect
23/05/2022
On Harran plain where Adam and Eve fell to Earth, legend reigns
23/05/2022